Validation of K-XRF bone lead measurement in young adults. by Hoppin, J A et al.
Validation of K-XRF Bone Lead Measurement in
Young Adults
Jane A. Hoppin,12Antonio C.A. Aro,3 Paige L. Williams,4 HowardHu,1'3
and P. Barry Ryan1
1Department of Environmental Health and 2Department of Epidemiology, Harvard School
of Public Health, Boston, MA 02115 USA; 3Channing Laboratory, Department of
Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
USA; 4Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115
USA
KXray rescea-(RF): ;;*efi:
tool for assssing U tt
lead n ocpationally exposed indiidual
and older adults. This sudy explores the;
possibility f ustgh n o yung
adult l M. e vir t
sure. Twenty..thrce college students agedi
18-21 years, were recruited for 2 hrofbone
lead ent. Bon lead merments
were nfin&om th saidsbaf tibaorper-
:of30 vr60 win. xn t a.-,....n.
mes ents were cmbie sotat each.:
subject had the equivt of two 60-mm
me*surement. The a onnao of], ~~~~~~~~~~~~~~ two bone-lead maueetinhspola- ~~~~~~~~~~~~~~~~~~~~~........'....i..
minerl, th a: men of 3. pg Pg bone
mineral. In a one s.amp -test, this mean,,
was s.gnificantly different from.
..(ptOA)00. A . ne.t.end with:age.wa.
zdetecte despitethe sm age rnge of our
population. By doubling the sp time,a
the reported measu.rement un.certainty
decreased bya factor..of,.:...1....... 5 resul.ng in.
*~~~~~~~~~~~~~~~~~~~~~~~~~. .......,, ..e.
.leadesaes. Powerclltions uing the
obseed:: variance estimates suggest that
with 80% power, differeces in bone lead:
conceion of 2 g bg bne L miner.al
can.be ientified in g Osof1.0.00t o all
er. Duelto the larewthin-personva.raonA
*in youg adults, Kma. ay not:yet be a
usfl ignsictooloindividua susbjects,
* W..k.*.;*..d H~~~~~~~~~~~~~~~~~~~....b.....
:scientsts trying t characterize lngPte.r.m lead expsre ad _s in te geea popu-.
lationor speciic s words-
bone lead measr lea, young adut
lead +5expsre Enirr Jfar PE et
~~..
Lead is a ubiquitous contaminant in our
environment. Lead is found in the food we
eat, the air we breathe, and the water we
drink. Even though recent regulations have
reduced the current input of lead into the
environment, lead persists in paint, soils,
dust, and plumbing in homes, schools, and
neighborhoods.
Lead is a xenobiotic, but it is found in
measurable levels in all individuals. Lead
concentration in blood is the most com-
monly used biological marker oflead expo-
sure. Recent exposure to lead can be detect-
ed by changes in blood lead concentration;
the half-life oflead in blood is estimated to
be approximately 35 days (1). Chronic ex-
posure to lead results in long-term storage
oflead in bone; in adults, 95% ofthe body
burden of lead is in bone (2,3). Autopsy
studies suggest that the concentration of
lead in bone increases with age and that
bone lead represents a lifetime integrated
measure of lead exposure (1). Bone lead
may serve as a reservoir for lifetime lead
exposure.
Over time, lead has been demonstrated
to have effects in humans at progressively
lower levels. Long-term developmental
deficits in children have been demonstrat-
ed in longitudinal studies at blood lead lev-
els less than 10-15 pg lead/dl blood (4,5),
and meta-analysis failed to identify a
threshold below which no effects are found
(6,7). Similarly low levels of blood lead
have been associated with elevations in
blood pressure in adults in both longitudi-
nal and cross-sectional investigations
(8-10).
Until recently, measurements of lead
burden in bone could only be taken at
autopsy or using a needle biopsy. With the
advent of K-X-ray fluorescence (K-XRF)
technology, bone lead levels can be mea-
sured in a noninvasive manner (11,12). K-
XRF analysis has been used to measure
bone lead in a variety of occupationally
and nonoccupationally exposed individuals
(12-15). However, a recent National
Academy ofSciences report (16) expressed
concern about the usefulness of K-XRF
technology in measuring bone lead levels
in nonoccupationally exposed adults due
to the potential for poor sensitivity at low
lead concentrations. Bellinger et al. (17)
cited a need for further improvements in
the precision of K-XRF to establish bone
lead as a useful biological marker ofchild-
hood lead absorption.
During the past 2 years, K-XRF tech-
nology has been improved to increase the
sensitivity of the measurement. Aro et al.
(18) demonstrated the consistency of K-
XRF results with atomic absorption mea-
surements for lead in standards of known
lead concentration. Gordon et al. (19)
recently demonstrated the reproducibility
ofbone lead measurements in vitro and in
a small sample of human subjects. The
current study focuses on issues concerning
the K-XRF in vivo limit of detection and
feasibility of measuring bone lead concen-
trations in young adults.
Methods
Volunteers were recruited from Boston-
area universities. All subjects were between
the ages of 18 and 21 years and had no
known occupational lead exposure. All
subjects were informed ofthe nature ofthe
procedure before bone lead measurement.
We measured bone lead concentration
in the left tibia of each subject using the
K-XRF bone lead scanning apparatus
developed by our research group. This
apparatus has recently been redesigned to
improve the sensitivity of bone lead mea-
surement, thereby allowing for bone lead
measurement in environmentally exposed
individuals. The bone lead scanner oper-
ates on the principle of K-X-ray fluores-
cence. The technical specifications and the
validation data are described in detail else-
where (18). Briefly, the instrument uses a
109Cd y-ray source of activity 1.11 GBq
and a high-purity germanium detector in a
back-scatter geometry (18). The source-to-
skin distance is approximately 2 cm.
Gamma and X-ray signals are shaped and
digitized and then acquired by a multi-
channel analyzer board in a personal com-
puter. At the completion of the measure-
ment time, the data are automatically
stored for analysis. A schematic ofthis sys-
tem is shown in Figure 1. In the 109Cd K-
XRF technique, lead X-rays are normalized
to the elastic scatter peak; the elastic scatter
peak is primarily due to elements of bone
mineral rather than to those ofhuman soft
tissue (20). Normalization renders the
accuracy ofmeasurement relatively insensi-
tive to variations in bone shape, size, and
density; overlying skin thickness; and to
minor subject movement (20). The preci-
sion of the measurement varies from per-
son to person and depends primarily on
the thickness of overlying tissue and the
mass of bone mineral sampled. The pres-
ence of sufficient bone mass is critical in
determining the lower age limit for bone
lead measurement.
An estimate of measurement uncer-
tainty accompanies each bone lead mea-
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surement made by K-XRF (for example, a
tibia lead measurement may read 15.5 ±
3.2 pg/g bone mineral). The estimate of
measurement uncertainty represents an
estimate ofthe standard deviation ofmul-
tiple measurements and is derived by a
goodness-of-fit calculation ofthe scatter in
the XRF spectrum. In experiments on a
cadaveric leg in which we took serial mea-
surements at multiple bone sites, these
estimates of measurement uncertainty
closely corresponded to the standard devia-
tions derived from repeated measurements;
however, Gordon et al. (154 estimated that
the reported uncertainty underestimates
the measurement variability by 20-30%.
Concentrations of lead reported from
K-XRF measurements using this K-XRF
instrument show good agreement with
lead concentrations measured using induc-
tively coupled plasma mass spectrometry
(ICP-MS) across a wide concentration
range (18). Calibration standards ranging
from 0 to 114 pg Pb/g bone mineral were
prepared using plaster ofparis and known
lead concentrations; these standards were
then analyzed multiple times by both K-
XRF and ICP-MS. The correlation
between K-XRF and ICP-MS measure-
ments was good (R2 = 0.9998), with a
slope close to unity (3 = 0.9968), demon-
strating that the K-XRF instrument has a
linear relationship with lead concentration
over the calibration range.
The effective radiation dose to the sub-
ject during an in vivo K-XRF measurement
is very low and can be compared to natural
background radiation (21). Todd et al.
(21) describes in detail the radiation
dosimetry studies involving similar K-XRF
instruments. We calculated the effective
doses using the new International
Commission on Radiological Protection
(22) recommendations. According to these
results, the effective dose from a single K-
XRF measurement of tibia is 0.2% and
0.1% of the average effective dose from a
dental and chest X-ray, respectively.
Similar dosimetry investigations of our
apparatus have demonstrated even lower
exposures, since the source strength is
approximately half the strength of Todd's
apparatus (2.2 versus 1.08 GBq). For our
bone lead scanner, the estimated effective
dose for a 60-min measurement of a 15-
year-old subject is less than 190 nSv (21).
For this pilot study, subjects came to
our K-XRF testing laboratory located in
the Brigham and Women's Hospital in
Boston, Massachusetts. Once at the facility,
the procedure was reviewed. All subjects
were asked about the presence ofmetal pins
in either lower leg. Ifmetal was not present
in the lower leg, subjects were seated in a
plastic resin chair, and the lower leg was
restrained with Velcro straps to minimize
movement during measurement. The mea-
surement location of the mid-shaft of the
left tibia was verified throughout the proce-
dure by the technician.
To remove extraneous sources of lead
from contaminating the measurement, the
measurement location was washed with a
50% solution of isopropyl alcohol before
sample collection. The test room was
cleaned each day with a HEPA-filtered
vacuum cleaner. After shielding the mea-
surement area with lead-free steel walls, the
area was monitored to determine that
there was no background lead contamina-
tion that could affect sample results.
Bone lead measurements were taken
from the mid-shaft of the left tibia for
periods of 30 or 60 min. Here and
throughout this paper, times refer to real
or clock time, rather than instrumental live
time. The collimator was positioned
perpendicular to and in the middle of the
Figure 1. Schematic of bone lead scanner. HpGe, high-purity germanium detector; LN2, liquid nitrogen;
ADC, analog-digital converter; MCA, multichannel analyzer.
anterior tibial surface. All measurements
were collected at the same bone location
over a 2-hr period. Subjects were allowed
to move between measurements. During
the sample collection time, subjects
completed exposure history questionnaires,
read magazines, and listened to music.
Technicians were present at all times dur-
ing the measurement to answer questions.
Each subject was measured for a total
of2 hr. In 14 subjects, 4 30-min measure-
ments were taken; in 7 subjects, 2 60-min
measurements were taken; and in 2 sub-
jects 1 60-min and 2 30-min measure-
ments were taken. For analytical purposes,
we combined 2 consecutive 30-min mea-
surements so that each subject had the
equivalent of2 60-min measurements.
Two bone lead concentrations were cal-
culated for each subject using the stored
lead spectra; these represent two 60-min
repeat measurements. For individuals ini-
tially assessed by 30-min measurements,
spectra from two consecutive 30-min mea-
surements were combined and then ana-
lyzed as one complete 60-min measure-
ment. The lead K-X-ray peaks were extract-
ed from the spectrum using the nonlinear
least-square fitting technique (23) with spe-
cial fitting functions developed by the
Birmingham University Group (20). The
fitting software generates the K-X-ray to
elastic ratio for each ofthe K-series X-rays.
Since some of the K-series X-rays have
greatervariability than others, the final lead
concentration was calculated from the
means of the a1, a2, PI, and 3 peaks
weighted by the inverse of their respective
variances. Figure 2 illustrates the location
ofthe al, a2, PI and 3 peaks in a 114 pg
Pb/g bone mineral lead standard. The con-
tributions ofthe different K-X-rays to over-
all precision are discussed elsewhere (20).
The fitting algorithm requires subtract-
ing a fitted background curve from the
actual data collected. Due to the statistical
nature ofthe counting procedure, it is pos-
sible, especially for very low lead concen-
trations, that the value determined by sub-
tracting the fitted background curve from
the observed data is less than zero. This
results in a negative value for the measured
concentration. Negative values are not dis-
carded; they represent the best estimate of
the lead concentration for the individual
and are thus useful in establishing the
shape of the concentration distribution
and in establishing the relative position of
an individual's bone lead concentration
within the population.
We performed statistical analyses to
investigate whether bone lead concentra-
tion was measurable in young adults and
to investigate to what extent bone lead
measurements were reproducible in this
age group. One-sample tests, correlation
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decrease in measurement uncertainty
resulted in reported measurement uncer-
tainty within or below the range of the
measured bone lead concentration. Based
on the uncertainty measurements, the
combination of the two 30-min measure-
ments does not appear to be different from
the complete 60-mmn measurements.
Mathematically, these are equivalent mea-
surements; statistical analysis, using linear
_ _ _ _ _* regression models which contained a
_____* dummy variable for combined measure-
ments, confirmed that there was no differ-
ence between the combined 30-min mea-
surements and the 60-min measurements.
The bone lead concentration in this
population is lowcompared to occupation-
*____ ally exposed subjects. The average of the
two 60-min measures ranged from -1.5 to
8.2 pg Pb/g bone mineral, with a sample
mean and standard deviation of 3.0 pg
Pb/g bone mineral and 2.3 pg Pb/g bone
52 58 64 70 76 82 88 94 100 106 mineral, respectively. Figure 3 presents a
histogram ofthe average bone lead concen-
Energy(keV) trations. The reported measurement error
associated with these 60-min estimates
ical K-XRF spectrum for a 117 pg Pb/g bone mineral lead standard. ranged from 2.4 to 4.8 pg Pb/g bone min-
eral, with a mean and standard deviation of
Ld repeated-measures techniques stant covariance estimated empirically 3.3 and 0.55 pg Pb/g bone mineral,
loyed to address these issues. from the observed data was assumed for all respectively. A one-sample t-test was used
Iy, the role of age on bone lead pairs ofmeasurements. to test the hypothesis that the mean ofthe
concentration was explored using regres- Results
sion analysis. All statistical analyses were
carried out using the statistical packages Twenty-three subje
STATA 3.1 (24) and SAS 6.09 (25). were recruited for t
The statistical analyses were conducted age ofpopulation wa
using two 60-min measurements per indi- of racial groups we
vidual. Correlation analysis and repeated- study subjects. Tat
measures models used the two samples per characteristics.
subject. For most ofthe analyses, the mean From Poisson cc
ofthese two measurements was used; these bling the sampling t
analyses included t-tests and linear regres- decrease in the mea
sion. This average value was used, rather by a factor of 12 (2
than creating one 120-min measurement, increase in the samj
because a 60-min measurement time is an average reducti
viewed as the longest feasible measurement uncertainty by a faci
time in young subjects. Use of this mea- tion in uncertainty l
sure helped provide more stable estimates rate measurement c
ofa subject's bone lead concentration. tion and allowed for
For regression analyses, bone lead data concentrations no
were weighted based on the reported esti-
mates ofuncertainty. Each observation was Table 1. Population ch weighted by the inverse of the squared subjects in eachcatego
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Figure 3. Distribution of bone lead concentration.
Table 2. Distribution of bone lead by age, sex,
and race: numberofsubjects in each category
Bone lead concentration
(pg Pb/g bone mineral)
Characteristic <1 1-4 >4 N
Age, years
18 4 5 0 9
19 2 4 4 10
20 0 1 3 4
Sex
Female 4 9 5 18
Male 2 1 2 5
Race (self-reported)
White 4 8 3 15
All nonwhites 2 2 4 8
African-American 0 0 2 2
Haitian 0 1 0 1
Hispanic 1 1 2 4
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observed bone lead distribution does not
differ from zero. This test indicated that
this hypothesis could be rejected
(p<0.0001), suggesting that bone lead is
measurable in young adults using this tech-
nique. Table 2 presents the bone lead dis-
tribution by age, sex, and race.
We used a variety ofstatistical methods
to evaluate the reproducibility of these
bone lead measurements. Using a paired t-
test, no difference between the means of
the two measurements was observed. The
observed Pearson correlation between the
two 60-min measurements was not signifi-
cantly different from zero (p = 0.3324);
nonparametric measures of correlation
showed similar results. These results sug-
gest that bone lead measurements for a
population with very low lead exposure are
reproducible; however, it may be due to
the small size of the sample. Reprodu-
cibility results for individuals are not as
convincing. Analysis ofvariance techniques
were used to determine whether individu-
als could be distinguished on the basis of
their bone lead results. Due to the large
within-person variance (approximately
twice the between-person variance), sub-
jects cannot be differentiated on the basis
of two bone lead measurements. This may
be due to the limited range oflead concen-
tration in this population. Implications of
this finding on sample size and power will
be discussed further.
An interesting unanticipated finding
was the demonstration of an effect of age
on bone lead concentration. Even given
the small age range, a statistically signifi-
cant increase of 1.5 pg Pb/g bone mineral
Pb per year (p = 0.0065) was estimated
using linear regression analysis based on
the average of the two 60-min measure-
ments; the intercept for this model is -25.8
pg Pb/g bone mineral Pb. Age may be con-
sidered to represent duration of environ-
mental exposure and not aging per se. The
)2 for this model was 0.3033, indicating
that age explained 30% of the variance in
bone lead concentration in a population
generally thought to be identical with
respect to age. The unweighted regression
model gave qualitatively similar results,
with an 1? of0.2981. Figure 4 presents the
weighted regression model for bone lead
and age. Regression diagnostics were per-
formed to evaluate the model; no outliers
were identified.
To take advantage of the presence of
the duplicate measures ofbone lead and to
account for the correlation between the
measures, two types of repeated-measure
models were employed. Due to software
constraints, the measurements ofbone lead
were not weighted for measurement uncer-
tainty. A multivariate analysis of variance
model (MANOVA) used both of the 60-
G=10
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Figure 4. Scatter plot and weighted regression line
of tibia bone lead level versus age in 23 adoles-
cents. Size ofthe diameter of each point is propor-
tional to the inverse of the estimate of uncertainty
for the bone-XRF measurement (the smaller the
point, the larger the estimated measurement
uncertainty). Univariate regression of bone lead on
age was Y= 1.5 X- 25.8, where Y= tibia bone lead
concentration (pg/g bone mineral), and X = age
(years); R2 = 0.3033.
min measurements for each subject as
dependent variables with age as the inde-
pendent variable; this model demonstrated
a statistically significant effect ofage on the
two measures (p = 0.0174). A repeated-
measures analysis of variance did not
demonstrate an effect of measurement
order (p = 0.7372); the age effect was sig-
nificant (p = 0.0070). These results suggest
that even in the presence of measurement
error, age plays a significant role in the pre-
diction ofbone lead concentration.
Discussion
The results ofthis study indicate the feasi-
bility ofusing K-XRF technology to inves-
tigate bone lead in young adults. In partic-
ular, we have demonstrated the ability of
this technique to detect lead in bones of
young, nonoccupationally exposed sub-
jects. Further, we have shown that trends
in bone lead concentration with age can be
discerned.
The average bone lead concentrations
measured here, ranging from -1.5 to 8.2 pg
Pb/g bone mineral, are consistent with
those seen in young adults by other investi-
gators. For example, in a follow-up study
of 18-22 year olds of the original
Needleman (27,28) cohort, Bellinger et al.
(17) found tibial lead concentrations rang-
ing from -9 to 19 pg Pb/g bone mineral,
with a sample mean and standard devia-
tion of 1.6 and 4.9 pg Pb/g bone mineral,
respectively. These were collected over a
30-min time period using a less sensitive
K-XRF apparatus. In a community-based
study of 101 individuals aged 11-70 years
using a half-hour measurement time,
Kosnett et al. (29) reported a mean tibial
bone lead concentration of 12.7 pg Pb/g
bone mineral with a range of-12 to 69 pg
Pb/g bone mineral for the entire popula-
tion; for the 14 individuals less than 20
years of age, the mean bone lead concen-
tration was not different from zero.
These results are also consistent with
results from cadaver studies. Cadaver stud-
ies supply highly accurate data because
samples can be analyzed multiple times by
atomic absorption spectroscopy (AAS).
Post-mortem studies are useful for compar-
ison purposes but are not feasible for the
longitudinal measurement of bone lead
concentrations in humans. In a post-
mortem study by Wittmers et al. (30) of
13 subjects aged 13-20 years, the average
bone lead concentration was 2.3 pg Pb/g
bone ash, with a standard deviation of3.6.
In a study offive children 11-16 years old
in England, Barry (31) reported an average
tibial bone lead concentration of 2.68 pg
Pb/g bone mineral (wet weight), with a
standard deviation of 1.06; the ashed
weight equivalent for this value is 4.8 pg
Pb/g bone mineral. These results are con-
sistent with our mean bone lead concentra-
tion of3.0 pg Pb/g bone mineral.
As expected, the concentrations of tib-
ial bone lead in this young adult popula-
tion were much lower than both occupa-
tionally exposed and nonexposed adult
populations. In a study conducted in
Finland, Erkkila et al. (32) reported aver-
age bone lead concentrations of 21.1 pg
Pb/g bone mineral, 32.4 pg Pb/g bone
mineral, 7.7 pg Pb/g bone mineral, and
3.5 pg Pb/g bone mineral for current lead
workers with an average exposure duration
of 12 years, former lead workers with an
average exposure duration of 15 years,
office workers in the lead factory, and
unexposed control workers, respectively.
Somervaille et al. (33) reported tibial bone
lead concentrations ranging from an aver-
age of 16.7 pg Pb/g bone mineral for non-
exposed workers to 54.8 pg Pb/g bone
mineral for lead factory workers.
With the improvement in measure-
ment sensitivity, we were able to detect an
age-related increase in bone lead that has
not been seen by other investigators study-
ing this age group (17,29). Cross-sectional
studies in adults using less sensitive equip-
ment (29,34) have demonstrated age-relat-
ed increases in bone lead concentration
beginning at approximately age 20.
Further analysis of the bone lead measure-
ments on the Needleman cohort (17) indi-
cates some interesting findings that may
merit further investigation. In the whole
population of 67 subjects, the unweighted
regression model for age as a predictor of
tibial bone lead concentration was not sig-
nificant (p= 0.3386, l2 = 0.0139); howev-
er, when the reported bone lead concentra-
tions were weighted by their reported mea-
surement uncertainty, a regression coeffi-
cient of 1.04 pg Pb/g bone mineral Pb per
year (SE = 0.637, p = 0.1064, R1 = 0.039)
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ed to the 51 subjects aged 18-21 years, an
unweighted regression coefficient of 1.53
pg Pb/g bone mineral Pb per year was
observed (SE = 0.9127, p = 0.0997, Ji =
0.0544); when the model was weighted for
measurement error, the parameter estimate
was 1.75 pg Pb/g bone mineral Pb per year
(SE = 0.7582), with a p-value of 0.0247
and an 1?2 for the model of0.0987. While
the J2 values for these models are not sug-
gestive of an important explanatory effect
ofage, the parameter estimates ofthe slope
are similar to that observed in this investi-
gation (,B = 1.5); this suggests that by
increasing the sensitivity ofbone lead mea-
surement, predictive models of bone lead
concentration may be developed for young
adults. Through the improvement in the
sensitivity ofthe K-XRF apparatus, we are
able to explain over 30% of the variation
in bone lead concentration as a function of
age over a very small age range with a small
sample size (n = 23).
In studies ofoccupationally and nonoc-
cupationally exposed adults, other investi-
gators have found an average increase in
bone lead concentration ranging from 0.38
to 0.41 pg lead per year (29,34-36); the
ages in these studies have ranged from 20
to 70 years. In both this study's data and
the Needleman cohort data, an average
increase of approximately 1.5 pg lead per
year was seen over a 3-year age range. The
95% confidence interval for the predicted
slope in our study (0.46, 2.5) excludes the
values seen for older adults. It should be
noted that all these studies are cross-sec-
tional, and the observed change with age
may have a variety of explanations; longi-
tudinal studies are necessary to distinguish
the effects ofsecular trends in environmen-
tal lead exposure from bone lead kinetics in
producing the observed change.
If the model correctly predicts the
trend of bone lead with age, then bone
lead concentrations should be measurable
in those subjects aged 18 years and older,
and, conversely, measuring bone lead in
subjects less than 18 years old may be diffi-
cult. However, due to the small sample size
and the model uncertainty, extrapolating
past the range ofthe observed data should
be done cautiously.
Since this is a pilot study focusing on
the ability to measure bone lead concentra-
tion, little effort was made to collect com-
plete information on potential confounders
which may alter the observed association
between age and bone lead. Data were col-
lected on housing characteristics, history of
lead poisoning, cigarette smoking, and
occupation and hobbies which may con-
tribute to lead exposure; the population
was relatively homogeneous with respect to
these exposures. No information was col-
lected on body size, dietary and drinking
habits, or pregnancy history. The distribu-
tions of other potential confounding fac-
tors, race and sex, were examined to see
how these varied relative to age and bone
lead. Chi-square tests did not indicate that
these factors were associated with age or
bone lead. Additionally, these variables
were not significant predictors ofbone lead
when included in the regression model. If
these or other factors were responsible for
increasing sample variability, then it is
unlikely that we would be able to show a
statistically significant effect of age, given
the small sample size. Other investigators
(29,34-36) have demonstrated that age is
the most important predictor ofbone lead
concentration; this study suggests that all
models predicting bone lead should
include age in the model regardless of the
age range in the sample. Sex is not antici-
pated to be a confounder in this age range;
Kosnett et al. (29) found an effect of sex
only in subjects greater than 55 years of
age. Larger studies over a small age range
are needed to investigate other factors asso-
ciated with lead storage in bone.
Even with current technological
improvements, there still is substantial
measurement uncertainty due to the small
amount oflead, incomplete bone mineral-
ization, and technological limitations.
However, power calculations based on a
two-sample t-test indicate that, even in the
presence of measurement error, a differ-
ence of2-3 pg Pb/g bone mineral lead can
be detected with 80% power with sample
sizes as small as 50 people per group. Due
to the relatively large variability within a
subject at low lead concentrations, K-XRF
currently would not be a good diagnostic
tool among individuals exposed to lower
levels of lead. For populations, however,
repeated measurements over time can be
used to investigate lead kinetics in bone.
One key observation from this pilot
study is the imperative to keep and
maintain a lead-free environment in the
measurement facility. Prior to study start-
up, we experienced difficulties due to lead
paint on walls, lead in cinder block behind
walls, and lead in aluminum wrappers for
alcohol swabs. Since the concentrations of
interest are at the low part-per-million
level, these and other potential lead sources
may bias results if they are not addressed
before sample collection.
K-XRF is a useful tool for environmental
epidemiological investigations ofbone lead
concentration in young adults. By recon-
figuring the apparatus, increasing the mea-
surement time, and maintaining a lead-free
measurement environment, we were able
to detect measurable levels of lead in the
bones of young adults. Because bone lead
concentrations can be assessed in such a
young population, longitudinal studies can
be used to investigate factors associated
with age as predictors for bone lead con-
centration. By evaluating environmental
factors and the concomitant increase or
decrease in bone lead concentrations, mod-
els can be developed for uptake of lead to
bones from blood and, ultimately, from
the environment.
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